Table 1. Demographic characteristics of NB patients and percentage of Oct-4+ cells in primary tumor samples and in bone marrow (BM) aspirate samples.
Patient primary tumor sample | Age (months) | Stage | % Oct-4+ cells |
---|---|---|---|
1 | < 12 | 1 | 12 |
2 | < 12 | 1 | 4 |
3 | < 12 | 1 | 14 |
4 | < 12 | 1 | 15 |
5 | < 12 | 1 | 30 |
6 | > 12 | 1 | 4 |
7 | > 12 | 2A | 0 |
8 | < 12 | 2A | 10 |
9 | > 12 | 2B | 10 |
10 | > 12 | 2B | 4 |
11 | > 12 | 2B | 2 |
12 | < 12 | 4s | 10 |
13 | < 12 | 4s | 0 |
14 | < 12 | 4s | 4 |
15 | > 12 | 4 | 2 |
16 | > 12 | 4 | 4 |
17 | > 12 | 4 | 15 |
18 | > 12 | 4 | 2 |
19 | > 12 | 4 | 10 |
20 | > 12 | 4 | 30 |
21 | > 12 | 4 | 15 |
22 | > 12 | 4 | 3 |
23 | > 12 | 4 | 15 |
Patient BM sample | Age (months) | Stage | % NB84+ cells | % Oct-4+/NB84+ cells |
---|---|---|---|---|
1 | > 12 | 4 | 30 | 0.2 |
2 | > 12 | 4 | 20 | 0.4 |
3 | > 12 | 4 | 70 | 0.15 |
4 | > 12 | 4 | 80 | 0.15 |
5 | > 12 | 4 | 30 | 0.4 |
6 | > 12 | 4 | 80 | 1.5 |
7 | > 12 | 4 | 60 | 0.2 |
8 | > 12 | 4 | 80 | 0.7 |
9 | > 12 | 4 | 10 | 0.8 |
10 | > 12 | 4 | 50 | 0.4 |